Roughly one in six people in the United States between the ages of 14 and 49 has HSV-2, the virus that most often causes genital herpes. That number comes from the CDC’s National Health and Nutrition Examination Survey, which tests blood samples from a representative sample of the population. The infection is very common, but most people who have it never receive a formal diagnosis because they never have symptoms or their symptoms are mild enough to be mistaken for something else.
What Exactly Is HSV-2?
HSV-2 stands for herpes simplex virus type 2. It is one of two herpes simplex viruses. The other, HSV-1, is the type most commonly associated with cold sores around the mouth, though HSV-1 can also cause genital herpes.
HSV-2 is a lifelong infection. Once the virus enters the body, it travels to nerve cells near the spinal cord and stays there in a dormant state. Periodically, the virus can reactivate and cause outbreaks of sores or blisters in the genital or anal area. Some people have frequent outbreaks. Many people have only one or two in their lifetime. Others never have a visible outbreak at all.
The key distinction is that having the virus is not the same as having symptoms. Blood tests can detect antibodies to HSV-2, which means a person has been infected at some point. That is different from a swab test, which only detects the virus when an active sore is present.
How Many People Have HSV-2 in the United States?
The most reliable estimate comes from the CDC’s national health survey. According to the most recent data, about 12 percent of people aged 14 to 49 in the United States are infected with HSV-2. That translates to roughly one in six people in that age range.
The number has actually declined over the past few decades. In the late 1980s and early 1990s, the infection rate was closer to 18 to 21 percent. The decline is likely due to a combination of safer sex practices, better education, and changes in sexual behavior. Still, the virus remains widespread.
It is important to understand that this 12 percent figure only counts people who have antibodies to HSV-2. It does not include people who have genital herpes caused by HSV-1. That is a separate and growing category.
How Many People Have HSV-2 Worldwide?
Globally, the numbers are much larger. The World Health Organization estimates that around 491 million people aged 15 to 49 were living with HSV-2 infection in 2016. That is roughly 13 percent of the world’s population in that age group.
Regional differences are significant. Prevalence is highest in Africa and the Western Pacific region. It is lower in Europe and the Americas. The reasons for these differences are complex and include access to healthcare, rates of condom use, and broader social and economic factors.
These are estimates, not exact counts. Many countries do not have reliable surveillance systems for genital herpes. The WHO numbers are modeled from available data and should be read as a reasonable approximation rather than a precise census.
Why Are So Many Cases Undiagnosed?
Most people with HSV-2 do not know they have it. Studies consistently show that 75 to 90 percent of people who test positive for HSV-2 antibodies report never having been diagnosed. This is not because they are hiding anything. It is because they never had symptoms they recognized as herpes.
When symptoms do occur, they can be subtle. A small red bump, a slight itch, or a tiny crack in the skin can be the only sign. People often mistake these for ingrown hairs, razor burn, jock itch, or friction irritation. The classic cluster of painful blisters that most people picture is not the typical presentation for everyone.
There is also the issue of asymptomatic shedding. Even when a person has no visible sores, the virus can be present on the skin surface. This means a person can transmit the virus to a partner without knowing they are infectious. This is one of the main reasons the infection spreads so effectively.
Does HSV-2 Prevalence Differ by Gender or Race?
Yes. The infection is not evenly distributed across the population. Women are infected at roughly twice the rate of men. About 16 percent of women aged 14 to 49 have HSV-2, compared to about 8 percent of men in the same age range. The reasons are partly biological — the virus transmits more easily from men to women during sex — and partly related to testing patterns.
Racial and ethnic differences are also significant. The CDC data shows that prevalence is higher among Black Americans than among white Americans. These differences are not genetic. They are tied to social determinants of health, including differences in access to healthcare, historical patterns of sexual networks, and other structural factors.
Age matters too. Prevalence rises steadily with age. Among people in their 40s, the rate is roughly double the rate among people in their late teens and early 20s. This is simply because older people have had more years of potential exposure.
How Is HSV-2 Transmitted?
HSV-2 is transmitted through direct skin-to-skin contact with an infected area. This most commonly happens during vaginal or anal sex. It can also be transmitted through oral sex, though HSV-2 prefers the genital area and is less likely to establish infection in the mouth.
Condoms reduce the risk of transmission significantly, but they do not eliminate it. The virus can be shed from skin areas that a condom does not cover, such as the base of the penis, the scrotum, or the labia. This is why the infection spreads even among people who consistently use condoms.
Antiviral medication also reduces transmission risk. Daily suppressive therapy with drugs like valacyclovir lowers both the frequency of outbreaks and the amount of asymptomatic shedding. Studies have shown that daily antiviral use reduces the risk of transmitting HSV-2 to a partner by about 50 percent.
It is not transmitted through shared toilets, towels, hot tubs, or swimming pools. The virus does not survive long outside the body. It requires direct skin contact to spread.
What Are the Symptoms of HSV-2?
When symptoms do appear, they typically start within 2 to 12 days after exposure. The first outbreak is usually the most severe. It can include multiple painful blisters in the genital area, flu-like symptoms, swollen lymph nodes, and pain during urination. The blisters eventually burst, form shallow ulcers, and then crust over and heal. The first outbreak can last 2 to 4 weeks.
Recurrent outbreaks are usually milder and shorter. Many people experience a tingling, burning, or itching sensation in the area a day or two before sores appear. This is called the prodrome. Recognizing the prodrome can help a person start antiviral treatment early, which can shorten the outbreak.
Some people have what is called atypical symptoms. These include small cracks in the skin, redness, or a mild burning sensation without any visible blister. These are easy to dismiss and easy to miss.
How Is HSV-2 Diagnosed?
There are two main ways to diagnose HSV-2. The first is a viral swab. A healthcare provider takes a sample from an active sore and sends it to a lab to test for the virus. This test is most accurate when the sore is fresh, ideally within 48 hours of appearing.
The second is a blood test that looks for antibodies. A positive antibody test means the person has been infected at some point, even if they have no current symptoms and no memory of ever having an outbreak. The CDC does not recommend routine HSV-2 blood testing for everyone. It recommends testing for people who have symptoms, people whose partners have genital herpes, and people who specifically request testing.
There is a common misconception that a Pap smear or a standard STD panel includes herpes testing. It does not. Most routine STD screenings test for chlamydia, gonorrhea, syphilis, and HIV. Herpes testing must be specifically requested.
Is There a Cure for HSV-2?
No cure exists. Antiviral medications can manage the infection, reduce the frequency of outbreaks, and lower the risk of transmission, but they do not clear the virus from the body. The virus remains in the nerve cells for life.
Vaccine research is ongoing. Several candidate vaccines are in clinical trials, but none has been approved for prevention or treatment. Some researchers are also exploring gene-editing approaches to remove the virus from infected cells, but these are in very early stages.
For now, the standard of care is antiviral medication taken either during outbreaks or daily as suppressive therapy. Many people also find that identifying their personal triggers — stress, illness, lack of sleep — helps them manage recurrence patterns.
Frequently Asked Questions
Can you get HSV-2 from a toilet seat?
No. The virus dies quickly outside the body and cannot survive on inanimate surfaces long enough to cause infection. HSV-2 requires direct skin-to-skin contact to spread.
Does a negative HSV-2 blood test mean I definitely do not have it?
No test is perfect. A negative result is highly reassuring, but there is a small window period after exposure before antibodies develop, and very early infections can be missed.
Can HSV-2 be transmitted when there are no symptoms?
Yes. This is called asymptomatic shedding, and it is a major reason the virus spreads so easily. The virus can be present on the skin even when no sores are visible.
Is HSV-2 the same as having genital herpes?
Not exactly. HSV-2 is the most common cause of genital herpes, but HSV-1 can also cause genital herpes through oral sex. The symptoms and management are similar regardless of which virus type is responsible.
